Publicacions
-
Català-Temprano A, Pastor-Anglada M, Caviedes-Cárdenas L, Malatesta R, Rives-Solà S, Vega-García N, Camós-Guijosa M and Fernández-Calotti P.
FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia
Oncotarget . 7(31): 49786-49799. Nº de cites: 12
-
Rovira N, Noguera-Julián A, Rives-Solà S, Berrueco R, Lahoz R and Fortuny-Guasch C.
Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants
EUROPEAN JOURNAL OF PEDIATRICS . 175(7): 1013-1017. Nº de cites: 9
-
Bautista F, Gallego S, Cañete A, Mora J, Diaz de Heredia C, Cruz-Martínez O, Fernández JM, Rives-Solà S, Madero L, Castel V, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M and Moreno L.
Landscape of early clinical trials for childhood and adolescence cancer in Spain
CLINICAL & TRANSLATIONAL ONCOLOGY . 18(7): 708-713. Nº de cites: 6
-
Gianesin K, Noguera-Julián A, Zanchetta M, Del Bianco P, Petrara MR, Freguja R, Rampon O, Fortuny-Guasch C, Camós-Guijosa M, Mozzo E, Giaquinto C and De Rossi A.
Premature aging and immune senescence in HIV-infected children
Aids . 30(9): 1363-1373. Nº de cites: 80
-
Prieto C, Stam RW, Agraz-Doblas A, Ballerini P, Camós-Guijosa M, Castaño J, Marschalek R, Bursen A, Varela I, Bueno C and Menendez P.
Activated KRAS Cooperates with MLL-AF4 to Promote Extramedullary Engraftment and Migration of Cord Blood CD34(+) HSPC But Is Insufficient to Initiate Leukemia
CANCER RESEARCH . 76(8): 2478-2489. Nº de cites: 35
-
Wlodarski MW, Hirabayashi S, Pastor V, Starý J, Hasle H, Masetti R, Dworzak M, Schmugge M, van den Heuvel-Eibrink M, Ussowicz M, De Moerloose B, Català-Temprano A, Smith OP, Sedlacek P, Lankester AC, Zecca M, Bordon V, Matthes-Martin S, Abrahamsson J, Kühl JS, Sykora KW, Albert MH, Przychodzien B, Maciejewski JP, Schwarz S, Göhring G, Schlegelberger B, Cseh A, Noellke P, Yoshimi A, Locatelli F, Baumann I, Strahm B, Niemeyer CM and EWOG-MDS.
Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents
Blood . 127(11): 1387-1397. Nº de cites: 283
-
Cseh AM, Niemeyer CM, Yoshimi A, Català-Temprano A, Frühwald MC, Hasle H, van den Heuvel-Eibrink MM, Lauten M, De Moerloose B, Smith OP, Bernig T, Gruhn B, Kulozik AE, Metzler M, Olcay L, Suttorp M, Furlan I, Strahm B and Flotho C.
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group
BRITISH JOURNAL OF HAEMATOLOGY . 172(6): 930-936. Nº de cites: 28
-
Berrueco R, Alonso-Saladrigues A, Martorell-Sampol L, Català-Temprano A, Ruiz-Llobet A, Toll T, Torrebadell-Burriel M, Naudo-Lahoz M, Camós-Guijosa M and Rives-Solà S.
Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening
PEDIATRIC BLOOD & CANCER . 62(7): 1195-1201. Nº de cites: 8
-
Barneda-Zahonero B, Collazo O, Azagra A, Fernández-Duran I, Serra-Musach J, Islam AB, Vega-García N, Malatesta R, Camós-Guijosa M, Gómez A, Román-González L, Vidal A, López-Bigas N, Villanueva A, Esteller M and Parra M.
The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma
CELL DEATH & DISEASE . 6: 1635. Nº de cites: 41
-
Niemeyer CM, Loh ML, Cseh A, Cooper T, Dvorak CC, Chan R, Xicoy B, Germing U, Kojima S, Manabe A, Dworzak M, De Moerloose B, Starý J, Smith OP, Masetti R, Català-Temprano A, Bergstraesser E, Ussowicz M, Fabri O, Baruchel A, Cavé H, Zwaan M, Locatelli F, Hasle H, van den Heuvel-Eibrink MM, Flotho C and Yoshimi A.
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
HAEMATOLOGICA . 100(1): 17-22. Nº de cites: 34